Epilepsy Syndromes in Children - Infantile Onset Flashcards
infantile onset
range from benign and self-limited to sever with significant encephalopathy
benign myoclonic epilepsy in infancy - onset
infants between 4mo and 3 years of age
benign myoclonic epilepsy in infancy - seizures
myoclonic seizures
benign myoclonic epilepsy in infancy - triggers
sensory stimuli, whether tactile, auditory, or photic
suggestive of reflex epilepsy
benign myoclonic epilepsy in infancy - episodes
episodes may be very subtle, especially at onset
brief head nods or eye rolling
eventually increase in frequency and involve altered responsiveness and sometimes falls
benign myoclonic epilepsy in infancy - family
family history of generalized epilepsy or febrile seizures is present in up to 1/3 of patients
benign myoclonic epilepsy in infancy - EEG
3-4Hz generalized spike- or polyspike-and-wave activity concomitant with myoclonic and sometimes a photoparoxysmal response
benign myoclonic epilepsy in infancy - symptoms
GTCs may be seen later in childhood or even early adolescence
benign myoclonic epilepsy in infancy - prognosis
long-term outlook is good
cognitive and behavioral impairments have been described
benign myoclonic epilepsy in infancy - genes
SCN1A mutation - potassium channelopathy
benign myoclonic epilepsy in infancy - medications
levitiracetam (keppra), valproate
- do not use dilantin, phenytoin, oxcarbazapine, carbazepine
benign epilepsy of infancy/benign familial infantile epilepsy - symptomology
staring, decreased responsiveness, cessation of activity, eye deviation, and head turning
apnea, cyanosis
evolution to generalized convulsive seizures
benign epilepsy of infancy/benign familial infantile epilepsy - frequency
clusters of seizures
benign epilepsy of infancy/benign familial infantile epilepsy - development
initially neurodevelopmentally normal
later development of other paroxysmal symptoms including kinesigenic dyskinesia, episodic ataxia, familial hemiplegic migraine, or a combination
benign epilepsy of infancy/benign familial infantile epilepsy - genetics
mutations of PRRT2
Autosomal dominant inheritance with variable penetrance
benign epilepsy of infancy/benign familial infantile epilepsy - treatment
pharmacoresponsive - particularly to medications used in focal epilepsy
- carbamazepine (tegretol), lamotrigine (lamictal), oxcarbazepine (trileptal), topiramate (topamax)
benign epilepsy of infancy/benign familial infantile epilepsy - prognosis
excellent for ultimate seizure remission and normal neurologic outcome other than development of movement disorders in some cases
epilepsy of infancy with migrating focal seizures
rare but severe epilepsy
epilepsy of infancy with migrating focal seizures - onset
following neonatal period but before 6 months of age
epilepsy of infancy with migrating focal seizures - symptomology
multifocal seizures that have a ping-pong migratory quality
clinically can look like GTCS
epilepsy of infancy with migrating focal seizures - prognosis
uniformly poor
epilepsy of infancy with migrating focal seizures - genetics
sodium channels: SCN1A and SCN2A
phospholipase metabolism: PCLB1
potassium channelopathies: KCNT1 and SLC12A5
epilepsy of infancy with migrating focal seizures - EEG
ping pong